{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:20:36Z","timestamp":1791645636298,"version":"4.3.4"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND AND OBJECTIVES<\/jats:title>\n                  <jats:p>Inappropriate vancomycin use is common in children\u2019s hospitals. We report a quality improvement (QI) intervention to reduce vancomycin use in our tertiary care PICU.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We retrospectively quantified the prevalence of infections caused by organisms requiring vancomycin therapy, including methicillin-resistant Staphylococcus aureus (MRSA), among patients with suspected bacterial infections. Guided by these data, we performed 3 QI interventions over a 3-year period, including (1) stakeholder education, (2) generation of a consensus-based guideline for empiric vancomycin use, and (3) implementation of this guideline through clinical decision support. Vancomycin use in days of therapy (DOT) per 1000 patient days was measured by using statistical process control charts. Balancing measures included frequency of bacteremia due to an organism requiring vancomycin not covered with empiric therapy, 30-day mortality, and cardiovascular, respiratory, and renal organ dysfunction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Among 1276 episodes of suspected bacterial infection, a total of 19 cases of bacteremia (1.5%) due to organisms requiring vancomycin therapy were identified, including 6 MRSA bacteremias (0.5%). During the 3-year QI project, overall vancomycin DOT per 1000 patient days in the PICU decreased from a baseline mean of 182 DOT per 1000 patient days to 109 DOT per 1000 patient days (a 40% reduction). All balancing measures were unchanged, and all cases of MRSA bacteremia were treated empirically with vancomycin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSION<\/jats:title>\n                  <jats:p>Our interventions reduced overall vancomycin use in the PICU without evidence of harm. Provider education and consensus building surrounding indications for empiric vancomycin use were key strategies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2021-052165","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T08:05:46Z","timestamp":1647331546000},"source":"Crossref","is-referenced-by-count":6,"title":["Improving Vancomycin Stewardship in Critically Ill Children"],"prefix":"10.1542","volume":"149","author":[{"given":"Kathleen","family":"Chiotos","sequence":"first","affiliation":[{"name":"Division of Critical Care Medicine, Department of Anesthesiology and Critical Care"},{"name":"Division of Infectious Diseases, Department of Pediatrics"},{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"},{"name":"Antimicrobial Stewardship Program"},{"name":"Pediatric Sepsis Program, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Anesthesiology and Critical Care"},{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"},{"name":"Pediatric Sepsis Program, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Hayes","sequence":"additional","affiliation":[{"name":"Antimicrobial Stewardship Program"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Dashefsky","sequence":"additional","affiliation":[{"name":"Pediatric Sepsis Program, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talene A.","family":"Metjian","sequence":"additional","affiliation":[{"name":"Antimicrobial Stewardship Program"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Woods-Hill","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Anesthesiology and Critical Care"},{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"},{"name":"Pediatric Sepsis Program, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Biedron","sequence":"additional","affiliation":[{"name":"Pediatric Sepsis Program, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Stinson","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Anesthesiology and Critical Care"},{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"},{"name":"Pediatric Sepsis Program, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon C.","family":"Ku","sequence":"additional","affiliation":[{"name":"Pediatric Sepsis Program, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Division of Emergency Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Robbins Tighe","sequence":"additional","affiliation":[{"name":"Pediatric Sepsis Program, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Anesthesiology and Critical Care"},{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"},{"name":"Pediatric Sepsis Program, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran","family":"Balamuth","sequence":"additional","affiliation":[{"name":"Pediatric Sepsis Program, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Division of Emergency Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Schriver","sequence":"additional","affiliation":[{"name":"Antimicrobial Stewardship Program"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Gerber","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"},{"name":"Antimicrobial Stewardship Program"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"issue":"6","key":"2022040102595937900_B1","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1097\/PCC.0b013e31828a846d","article-title":"Point prevalence survey of antimicrobial utilization in the cardiac and pediatric critical care unit","volume":"14","author":"Blinova","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"2022040102595937900_B2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/PCC.0000000000001535","article-title":"Variability in antibiotic use across PICUs","volume":"19","author":"Brogan","year":"2018","journal-title":"Pediatr Crit Care Med"},{"issue":"8","key":"2022040102595937900_B3","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1093\/cid\/ciaa036","article-title":"Appropriateness of antibiotic prescribing in United States children\u2019s hospitals: a national point prevalence survey","volume":"71","author":"Tribble","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2022040102595937900_B4","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.clinthera.2019.05.008","article-title":"Hospital-wide description of clinical indications for pediatric anti-infective use","volume":"41","author":"Williams","year":"2019","journal-title":"Clin Ther"},{"issue":"1","key":"2022040102595937900_B5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/ice.2019.297","article-title":"Antimicrobial-resistant pathogens associated with pediatric healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017","volume":"41","author":"Weiner-Lastinger","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"2022040102595937900_B6","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2022040102595937900_B7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"issue":"1","key":"2022040102595937900_B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2022040102595937900_B9","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2022040102595937900_B10","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2022040102595937900_B11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/AAC.04523-14","article-title":"Inappropriate continued empirical vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureus","volume":"59","author":"Kim","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2022040102595937900_B12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1017\/ice.2018.123","article-title":"Rate of positive cultures necessitating definitive treatment in patients receiving empiric vancomycin therapy","volume":"39","author":"Waters","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"2022040102595937900_B13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12879-018-3081-1","article-title":"Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasi-experimental study in a region of high MRSA prevalence","volume":"18","author":"Choe","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2022040102595937900_B14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2334-7-88","article-title":"Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study","volume":"7","author":"Junior","year":"2007","journal-title":"BMC Infect Dis"},{"issue":"9","key":"2022040102595937900_B15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.15585\/mmwr.mm6809e2","article-title":"Vital signs: trends in Staphylococcus aureus infections in veterans affairs medical centers - United States, 2005-2017","volume":"68","author":"Jones","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"2022040102595937900_B16","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/cid\/civ629","article-title":"Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006-2010","volume":"61","author":"Jones","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2022040102595937900_B17","doi-asserted-by":"crossref","first-page":"e20153099","DOI":"10.1542\/peds.2015-3099","article-title":"Changing susceptibility of Staphylococcus aureus in a US pediatric population","volume":"137","author":"Sutter","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"2022040102595937900_B18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1017\/ice.2017.98","article-title":"Variation in empiric coverage versus detection of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in hospitalizations for community-onset pneumonia across 128 US veterans affairs medical centers","volume":"38","author":"Jones","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"2022040102595937900_B19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamainternmed.2019.7495","article-title":"Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia","volume":"180","author":"Jones","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"10","key":"2022040102595937900_B20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1473-3099(12)70151-2","article-title":"Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study","volume":"12","author":"Hranjec","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2022040102595937900_B21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jpeds.2010.08.019","article-title":"Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children","volume":"158","author":"McKamy","year":"2011","journal-title":"J Pediatr"},{"issue":"12","key":"2022040102595937900_B22","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/1060028014549185","article-title":"Factors associated with acute kidney injury in children receiving vancomycin","volume":"48","author":"Sinclair","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"1","key":"2022040102595937900_B23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40121-013-0004-8","article-title":"Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children","volume":"2","author":"Ragab","year":"2013","journal-title":"Infect Dis Ther"},{"issue":"9","key":"2022040102595937900_B24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/INF.0000000000002391","article-title":"Vancomycin-associated nephrotoxicity and risk factors in critically ill children without preexisting renal injury","volume":"38","author":"Feiten","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"2022040102595937900_B25","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/INF.0000000000001882","article-title":"Nephrotoxicity with vancomycin in the pediatric population: a systematic review and meta-analysis","volume":"37","author":"Fiorito","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"2022040102595937900_B26","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2022040102595937900_B27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/00224065.1987.11979073","article-title":"Technical aids: journal of quality technology","volume":"16","author":"Nelson","year":"1984","journal-title":"J Qual Technol"},{"issue":"4","key":"2022040102595937900_B28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jpids\/piz064","article-title":"Limiting vancomycin exposure in pediatric oncology patients with febrile neutropenia may be associated with decreased vancomycin-resistant enterococcus incidence","volume":"9","author":"Karandikar","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"3","key":"2022040102595937900_B29","first-page":"e36","article-title":"Impact of an antimicrobial stewardship program on antibiotic use at a nonfreestanding children\u2019s hospital","volume":"6","author":"Turner","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"5","key":"2022040102595937900_B30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/INF.0000000000000615","article-title":"Implications and impact of prior authorization policy on vancomycin use at a tertiary pediatric teaching hospital","volume":"34","author":"Chan","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"2022040102595937900_B31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/INF.0b013e3181d683f8","article-title":"Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital","volume":"29","author":"Di Pentima","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"2022040102595937900_B32","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1093\/jpids\/piy031","article-title":"Antimicrobial stewardship program in a pediatric intensive care unit","volume":"7","author":"Aizawa","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"4","key":"2022040102595937900_B33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1086\/664757","article-title":"Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis","volume":"33","author":"Elligsen","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"2022040102595937900_B34","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/CCM.0b013e31828e9863","article-title":"Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome","volume":"41","author":"Rimawi","year":"2013","journal-title":"Crit Care Med"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-052165\/1275675\/peds_2021052165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-052165\/1275675\/peds_2021052165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:03:11Z","timestamp":1648782191000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/149\/4\/e2021052165\/185402\/Improving-Vancomycin-Stewardship-in-Critically-Ill"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,3,15]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-052165","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"article-number":"e2021052165"}}